InspireMD Statistics

Total Valuation

InspireMD has a market cap or net worth of $68.86 million. The enterprise value is $29.69 million.

Market Cap	68.86M
Enterprise Value	29.69M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

InspireMD has 26.08 million shares outstanding. The number of shares has increased by 112.45% in one year.

Current Share Class	26.08M
Shares Outstanding	26.08M
Shares Change (YoY)	+112.45%
Shares Change (QoQ)	+34.82%
Owned by Insiders (%)	20.75%
Owned by Institutions (%)	10.14%
Float	10.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.69
Forward PS	6.17
PB Ratio	1.64
P/TBV Ratio	1.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.39, with a Debt / Equity ratio of 0.03.

Current Ratio	6.39
Quick Ratio	5.87
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.75% and return on invested capital (ROIC) is -42.83%.

Return on Equity (ROE)	-66.75%
Return on Assets (ROA)	-37.24%
Return on Capital (ROIC)	-42.83%
Revenue Per Employee	$103,348
Profits Per Employee	-$427,818
Employee Count	66
Asset Turnover	0.14
Inventory Turnover	2.46

Taxes

In the past 12 months, InspireMD has paid $65,000 in taxes.

Income Tax	65,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.43% in the last 52 weeks. The beta is 0.93, so InspireMD's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-9.43%
50-Day Moving Average	2.57
200-Day Moving Average	2.54
Relative Strength Index (RSI)	59.08
Average Volume (20 Days)	35,440

Short Selling Information

The latest short interest is 79,595, so 0.31% of the outstanding shares have been sold short.

Short Interest	79,595
Short Previous Month	44,000
Short % of Shares Out	0.31%
Short % of Float	0.77%
Short Ratio (days to cover)	3.72

Income Statement

In the last 12 months, InspireMD had revenue of $6.82 million and -$28.24 million in losses. Loss per share was -$0.74.

Revenue	6.82M
Gross Profit	1.54M
Operating Income	-29.94M
Pretax Income	-25.46M
Net Income	-28.24M
EBITDA	-29.68M
EBIT	-29.94M
Loss Per Share	-$0.74

Full Income Statement

Balance Sheet

The company has $40.40 million in cash and $1.23 million in debt, giving a net cash position of $39.17 million or $1.50 per share.

Cash & Cash Equivalents	40.40M
Total Debt	1.23M
Net Cash	39.17M
Net Cash Per Share	$1.50
Equity (Book Value)	41.35M
Book Value Per Share	1.61
Working Capital	39.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.30M
Capital Expenditures	-1.31M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	22.61%
Operating Margin	-439.00%
Pretax Margin	-413.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-283.48%

Dividends & Yields

InspireMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-112.45%
Shareholder Yield	-112.45%
Earnings Yield	-41.00%
FCF Yield	n/a

Analyst Forecast

The average price target for InspireMD is $4.50, which is 70.46% higher than the current price. The consensus rating is "Buy".

Price Target	$4.50
Price Target Difference	70.46%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	67.99%
EPS Growth Forecast (5Y)	-16.56%

Stock Forecasts

Stock Splits

The last stock split was on April 27, 2021. It was a reverse split with a ratio of 0.0666666667:1.

Last Split Date	Apr 27, 2021
Split Type	Reverse
Split Ratio	0.0666666667:1

Scores

InspireMD has an Altman Z-Score of -3.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.61
Piotroski F-Score	1